JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Asunaprevir (formerly known as BMS-650032, brand name in Japan and Russia: Sunvepra) is a potent and orally bioavailable small molecule inhibitor of the hepatitis C virus (HCV) enzyme serine protease NS3 with an IC50 of 0.2 nM-3.5 nM. Hepatitis C virus (HCV) enzyme serine protease NS3 is necessary for protein processing during viral replication. Asunaprevir is an experimental drug candidate for the treatment of hepatitis C. It is being tested in combination with pegylated interferon and ribavirin, as well as in interferon-free regimens with other direct-acting antiviral agents including daclatasvir. It is currently in Phase III clinical trials.
References: Front Microbiol. 2017; 8: 668; Antimicrob Agents Chemother. 2012 Oct; 56(10):5387-96.
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!